1. Wang, Feng, Zhao, Miao, Jiang, Yuehong, Zhou, Dahong, Dong, Zipu. 2022. LncRNA UBE2R2-AS1, as prognostic marker, promotes cell proliferation and EMT in prostate cancer. In Histology and histopathology, 38, 637-645. doi:10.14670/HH-18-505. https://pubmed.ncbi.nlm.nih.gov/35916204/
2. Xu, Wu, Che, Dan-Dan, Chen, Liang, Liu, Qing, Pan, Ya-Wen. 2021. UBE2R2-AS1 Inhibits Xenograft Growth in Nude Mice and Correlates with a Positive Prognosis in Glioma. In Journal of molecular neuroscience : MN, 71, 1605-1613. doi:10.1007/s12031-021-01793-y. https://pubmed.ncbi.nlm.nih.gov/33528791/
3. Liu, Jie, Zhu, Guoguo, Xu, Siya, Lu, Qiping, Tang, Zhongzhi. 2017. Analysis of miRNA expression profiling in human umbilical vein endothelial cells affected by heat stress. In International journal of molecular medicine, 40, 1719-1730. doi:10.3892/ijmm.2017.3174. https://pubmed.ncbi.nlm.nih.gov/29039486/
4. Zhang, Liwei, Jin, Yue, Yang, Hao, Shi, Yongheng, Wang, Yu. . SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination. In Carcinogenesis, 40, 1492-1503. doi:10.1093/carcin/bgz078. https://pubmed.ncbi.nlm.nih.gov/31002112/
智鼠故事 
